CAS: 179324-69-7
Molecular Formula: C19H25BN4O4
Molecular weight:384.24
Appearance:white powder
Density: 1.214g/cm3
Melting point:122-124°C
Use :Bortezomib, a novel first-in-class proteasome inhibitor, has been a major break through in the treatment of multiple myeloma. It is currently approved for the treatment of myeloma in the relapsed setting post transplant or as a second line treatment in patients unsuitable for transplantation.
Bortezomib
Send Enquiry Online
This form is unable to receive your inquiry from aol, hotmail, gmail or others but company email address.For more information OR other products. Please contact us by Email, Tel, Fax or Send online enquiry. We will reply you as soon as possible.
1. Email: sales@chemicalspharm.com
2. Tel: +86 592 5365887